Intravenous immunoglobulin–refractory necrobiotic xanthogranuloma successfully treated with tofacitinib 2% cream

• Neda Shahriari, MD,
• Daniel R. Mazori, MD,
• Joseph F. Merola, MD, MMSc

Affiliations

Neda Shahriari, MD

Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts; Correspondence to: Neda Shahriari, MD, Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, 221 Longwood Avenue Boston, MA 02115.

Daniel R. Mazori, MD

Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York

Joseph F. Merola, MD, MMSc

Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts; Division of Rheumatology, Inflammation, and Immunity, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts